Brush Up on Biosimilars

January 2025

You’ll see more biosimilar use...now that there are over 60 available in the US. And over 16 were approved in 2024 alone.

For example, there are now several biosimilars approved for ustekinumab (Stelara), such as ustekinumab-kfce (Yesintek).

Keep in mind, biosimilars aren’t generics. It’s not possible to create an exact copy of the original reference product...since biologics contain larger, more complex molecules than most traditional drugs.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Critical Care Help Prevent TBI Complications
Obstetrics Help Conserve RhIG Supply During Nationwide Shortages
Parkinson's Disease Prevent Mishaps With Carbidopa/Levodopa Options
Pertussis Reduce Pertussis With Vaccination and Antibiotics
Immunizations Check You’re Dispensing the Right Meningococcal Vaccine
Biosimilars Brush Up on Biosimilars
Compounding Ensure Your Sterile Compounding Policies Align With USP 797
Schizophrenia Watch for Xanomeline/Trospium to Treat Schizophrenia

Brush Up on Biosimilars

Practical advice for a better career, with unlimited access to CE

Table of Contents